Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
7 hedge funds and large institutions have $241K invested in Altamira Therapeutics Ltd in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
13% less funds holding
Funds holding: 8 → 7 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
72% less capital invested
Capital invested by funds: $856K → $241K (-$615K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$36.9K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$29K |
| 3 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$26.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$206K |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$151K |
| 3 |
Morgan Stanley
New York
|
-$89.5K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $92K | -$89.5K | -34 | -52% |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $54K | +$29K | +11 | +138% |
|
|
VF
3
Virtu Financial
New York
| $40K | +$36.9K | +14 | New |
|
|
CLOS
4
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| $28K | +$26.3K | +10 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| $21K | +$18.4K | +7 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $6K | – | – | – |
|
|
SM
7
Sabby Management
Miami Beach,
Florida
| – | -$206K | -33 | Closed |
|
|
BG
8
Bellevue Group
Kuesnacht,
Switzerland
| – | -$151K | -24 | Closed |
|
|
ARTA
9
A.R.T. Advisors
New York
| – | -$15K | -2 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$10K | -2 | Closed |
|
CYTO Hedge Fund Activity: Q3 2018 in Review
7 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2018, worth a combined $241K — down 72% from $856K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CYTO and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $36.9K. The largest seller was Sabby Management, exiting entirely with an estimated $206K sold.
- 7 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2018, down from 8 in Q2 2018.
- Funds reported $241K of Altamira Therapeutics Ltd stock for Q3 2018, down 72% quarter-over-quarter.
- 3 funds opened new Altamira Therapeutics Ltd positions in Q3 2018 and 4 closed out, a net change of -1 holder.
- The largest Altamira Therapeutics Ltd buyer in Q3 2018 was Virtu Financial, an estimated $36.9K added.
- The largest Altamira Therapeutics Ltd seller in Q3 2018 was Sabby Management, an estimated $206K sold.
Based on aggregated 13F filings for Q3 2018.